CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patterson, L.
Right arrow Articles by Parlow, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patterson, L.
Right arrow Articles by Parlow, J. L.
Canadian Journal of Anesthesia 48:768-772 (2001)
© Canadian Anesthesiologists' Society, 2001

Regional Anesthesia and Pain

The addition of fentanyl does not alter the extent of spread of intrathecal isobaric bupivacaine in clinical practice

[En clinique, l'addition de fentanyl ne modifie pas l'importance de la diffusion de bupivacaïne isobare intrathécale]

Lindsey Patterson, MB FRCA, Nicole Avery, MSc, Philip Chan, BSc and Joel L. Parlow, MD MSc FRCPC

From the Department of Anesthesiology, Queen's University, Kingston, Ontario, Canada.

Address correspondence to: Dr. Joel L. Parlow, Department of Anesthesiology, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada. Phone: 613-548-7827; Fax: 613-548-1375; Email: parlowj{at}post.queensu.ca

Purpose: Fentanyl is commonly added to intrathecal local anesthetic solutions. In vitro data has shown fentanyl to render isobaric local anesthetics hypobaric, and alter the spread in artificial cerebrospinal fluid. This study examined whether the addition of fentanyl to isobaric bupivacaine with morphine leads to a clinically important alteration in the extent of spread of anesthesia.

Methods: Forty-four ASA I–III patients undergoing lower limb orthopedic procedures completed this double-blind, placebo-controlled trial. Patients were randomized into one of two groups, receiving intrathecal bupivacaine 15 mg and preservative-free morphine 200 µg without (Control group), or with the addition of fentanyl 0.02 mg (Fentanyl group). Patients were maintained at a slight head-up tilt. Variables studied over three hours included sensory level to cold and pinprick, motor blockade (Bromage scale), and circulatory data.

Results: No differences existed between the Fentanyl and Control groups with respect to highest level of block for cold: T4 (T2–T5) vs T3.5 (T3–T8) respectively (median, 95% confidence interval) or pinprick: T4 (T3–T6) vs T4.5 (T3–T8). Similarly, there was no difference in the time taken to reach maximum block height to cold (20 ± 9 vs 23 ± 13 min, mean ± SD) or pinprick (20 ± 9 vs 24 ± 13 min).

Conclusion: The addition of fentanyl 0.02 mg to 0.5% bupivacaine with morphine does not affect the maximal block height or time to maximal block in clinical practice.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
N. Akerman, S. Saxena, R. Wilson, M. Columb, and G. Lyons
Effect of intrathecal diamorphine on block height during spinal anaesthesia for Caesarean section with bupivacaine
Br. J. Anaesth., June 1, 2005; 94(6): 843 - 847.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
G. Hocking and J. A. W. Wildsmith
Intrathecal drug spread
Br. J. Anaesth., October 1, 2004; 93(4): 568 - 578.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.